期刊文献+

微RNA-224对前列腺癌细胞生物学行为的影响 被引量:4

Effects of microRNA-224 on biological behavior of prostate cancer
原文传递
导出
摘要 目的:探讨微RNA-224(miR-224)对前列腺癌细胞增殖、凋亡、侵袭及转移的影响。方法构建携带过表达miR-224的重组慢病毒载体,分别转染前列腺癌细胞株PC3和LNCaP为miR-224过表达组,以转染空白载体的PC3和LNCaP为空载体对照组。实时荧光定量PCR检测miR-224在各组细胞中的表达,应用细胞增殖实验、划痕实验、细胞侵袭实验和流式细胞术检测各组细胞的增殖、迁移、侵袭和凋亡,建立裸鼠皮下移植瘤模型并观察miR-224对肿瘤生长的影响。结果与空载体对照组比较,miR-224过表达组的miR-224表达均显著上调(均P〈0.01)。与空载体对照组比较,miR-224过表达组细胞增殖能力显著下降(均P〈0.05)。划痕实验显示miR-224显著抑制前列腺癌细胞迁移(均P〈0.01)。流式细胞术显示过表达miR-224促进前列腺癌细胞凋亡(均P〈0.01)。细胞侵袭实验显示miR-224表达升高减弱肿瘤细胞的侵袭能力(均P〈0.05)。裸鼠移植瘤实验表明miR-224表达升高抑制移植瘤生长。结论 miR-224在前列腺癌中具有肿瘤抑制作用。 Objective To investigate the effects of microRNA-224 (miRNA-224) on the proliferation,apoptosis,invasion and migration of prostate cancer. Methods The recombinant lentiviral vectors with overexpressed miR-224 were established to transfect prostate cancer cell lines PC3 and LNCaP (overexpressed miR-224 group),and empty vectors to transfect PC3 and LNCaP (empty vector control group). Real-time fluorescence quantitative PCR was used to determine the expression of miR-224 in each group. Using cell proliferation assay ,scratch assay ,cell invasion assay and flow cytometry to determine cell proliferation,migration,invasion and apoptosis in each group. The subcutaneous tumor xenograft models in nude mice were established ,and the effects of miR-224 on tumor growth were determined. Results Compared with the empty vector control group,the miR-224 expression was significantly increased (both P〈0.01)and the cell proliferation was significantly decreased(all P〈0.05)in the overexpressed miR-224 group. Scratch assay showed that miR-224 significantly inhibited prostate cancer cell migration(both P〈0.01). Flow cytometry showed that overexpressed miR-224 promoted prostate cancer cell apoptosis(both P〈0.01). Cell invasion assay showed that the increased expression of miR-224 decreased the invasion of tumor cells (both P〈0.05). The xenograft tumor of prostate cancer cell in nude mice showed that the increased expression of miR-224 inhibited the growth of xenograft tumor. Conclusion MiR-224 plays a role of tumor inhibition in prostate cancer.
出处 《中华生物医学工程杂志》 CAS 2016年第1期7-11,共5页 Chinese Journal of Biomedical Engineering
关键词 微RNA-224 前列腺肿瘤 细胞增殖 侵袭 肿瘤 MicroRNA-224 Prostatic neoplasms Cell proliferation Invasiveness,neoplasm
  • 相关文献

参考文献17

  • 1Kong YW, Ferland-McCollough D, Jackson TJ, et al. microRNAs in cancer management [J]. Lancet Oncol, 2012, 13 (6) : e249-258.
  • 2杨丽媛,彭小芳,刘海英.微RNA-140-3p的研究进展[J].中华生物医学工程杂志,2015,21(4):378-382. 被引量:2
  • 3Prueitt RL, Yi M, Hudson RS, et al. Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer [J]. Prostate, 2008, 68 ( 11 ) : 1152-1164.
  • 4Zhu S, Sachdeva M, Wu F, et al. Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner [J]. Oncogene, 2010, 29(12): 1763-1772.
  • 5Fellenberg J, Saehr H, Lehner B, et al. A microRNA signature differentiates between giant cell tumor derived neoplastic stromal cells and mesenchymal stem ceils [J]. Cancer Lett, 2012, 321 (2): 162-168.
  • 6DOh 10.1016/j.canlet.2012.01.043. Bray F, Sankila R, Ferlay J, et al. Estimates of cancer incidence and mortality in Europe in 1995 [J]. Eur J Cancer, 2002, 38( 1 ) : 99-166.
  • 7瞿虎,汪中扬,邹自灏,毛晓鹏.前列腺特异性膜抗原定量检测在前列腺良恶性疾病诊断中的应用[J].广州医学院学报,2012,40(6):14-17. 被引量:1
  • 8Sun X, Jiao X, Pestell TG, et al. MicroRNAs and cancer stem cells: the sword and the shield [J]. Oncogene, 2014, 33 (42): 4967-4977.
  • 9Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis [Jl. Cancer Cell, 2006, 9(3) : 189-198.
  • 10Iorio MV, Visone R, Di Leva G, et al. MicroRNA signatures in human ovarian cancer [J]. Cancer Res, 2007, 67 (18) : 8699- 8707.

二级参考文献15

  • 1Xiao Y, Chen J, Luo YF, et al. Detection of P504S in prostatic adenocarcinomas [ J]. Natl Med J China,2004, 84(16) :1362-1366.
  • 2Zhang L, Ji G, Li X, et al. fPSA/tPSA ratio optimize the early diagnosis is in the prostate cancer [ J ]. Chin J Androl, 2004,10(8) :582-585.
  • 3Horoszewicz S, Kawinski E, Murphy GP. Monoclonal antibodies to a new antigenic marker in epithelial prostatic ceils and serum of prostatic cancer patients [ J ]. Anticancer Res, 1987, 7(5B) :927-935.
  • 4Birtle A J, Freeman A, Masters JR, et al. Tumour markers for managing men who present with metastatic prostate cancer and serum prostate-specific antigen levels of < lOng/mL[J]. BJU Int, 2005, 96(3): 303-307.
  • 5Murphy GP, Holmes EH, Boynton AL, et al. Comparison of prostate specific antigen, prostate specific membrane antigen, and LNCaP-based enzyme-linked immunosorbent assays in prostatic cancer patients and patients with benign prostatic enlargement[J]. Prostate, 1995, 26 (3) : 164-168.
  • 6Rochon YP, Horoszewicz JS, Boynton AL, et al. Western blot assay for prostate-specific membrane antigen in serum of prostate cancer patients [ J]. Prostate 1994, 25 (4) : 219-223.
  • 7Israeli RS, Miller WH Jr, Su SL, et al. Sensitive detection of prostatic hematogenous tumor cell dissemination using prostate specific antigen and prostate specific membrane- derived primers in the polymerase chain reaction [ J ]. J Urol, 1995, 153(3 Pt 1): 573-577.
  • 8Xiao Z, Adam BL, Cazares LH, et ah Quantxtatmn oi serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease [ J ]. Cancer Res, 2001, 61 (16) : 6029-6033.
  • 9Llanes L, Ferruelo A, POez A, et al. The clinical utility of the prostate specific membrane antigen reverse- transcription/polymerase chain reaction to detect circulating prostate cells: an analysis in healthy men and women[J]. BJU Int, 2002, 89(9) : 882-885.
  • 10欧阳永日,朱保义,王希,林芳,陈曦,任继鸿,张惠中,卫军霞,董轲.miR-140—3p在人肺腺癌A549细胞顺铂化疗敏感性中的作用研究[J].现代检验医学杂志,2013,28(4):5-8. 被引量:1

共引文献1

同被引文献33

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部